TREPROSTINIL

TREPROSTINIL was reported 127765 times

These side effects are most commonly reported by patients taking TREPROSTINIL:

# Side effect Count
0 DYSPNOEA 21943
1 HEADACHE 17829
2 DIARRHOEA 14240
3 NAUSEA 12742
4 COUGH 12264
5 DIZZINESS 9884
6 FATIGUE 9810
7 DEATH 9125
8 VOMITING 6464
9 HYPOTENSION 5902
10 INFUSION SITE PAIN 5800
11 PNEUMONIA 5767
12 MALAISE 5690
13 FLUID RETENTION 5150
14 OXYGEN SATURATION DECREASED 5148
15 PAIN IN EXTREMITY 5026
16 CHEST PAIN 4804
17 PAIN 4697
18 PULMONARY ARTERIAL HYPERTENSION 4511
19 DYSPNOEA EXERTIONAL 4491
20 ASTHENIA 4467
21 OFF LABEL USE 4466
22 WEIGHT DECREASED 4006
23 FLUSHING 3923
24 OEDEMA PERIPHERAL 3705
25 PAIN IN JAW 3670
26 DECREASED APPETITE 3605
27 FEELING ABNORMAL 3361
28 INFUSION SITE ERYTHEMA 3361
29 PERIPHERAL SWELLING 3293
30 FALL 3205
31 PULMONARY HYPERTENSION 2890
32 SYNCOPE 2888
33 CHEST DISCOMFORT 2883
34 NASOPHARYNGITIS 2866
35 THERAPY NON-RESPONDER 2818
36 ARTHRALGIA 2812
37 ABDOMINAL DISCOMFORT 2751
38 THROAT IRRITATION 2665
39 NASAL CONGESTION 2637
40 PALPITATIONS 2588
41 CONDITION AGGRAVATED 2559
42 EPISTAXIS 2540
43 PYREXIA 2434
44 OEDEMA 2429
45 WEIGHT INCREASED 2403
46 ABDOMINAL PAIN UPPER 2329
47 PRODUCTIVE COUGH 2324
48 BACK PAIN 2286
49 PRODUCT DOSE OMISSION ISSUE 2272
50 OROPHARYNGEAL PAIN 2243
51 HEART RATE INCREASED 2099
52 DRUG DOSE OMISSION 2096
53 DERMATITIS CONTACT 1983
54 INFUSION SITE SWELLING 1939
55 ANXIETY 1915
56 BLOOD PRESSURE DECREASED 1887
57 PRODUCT USE ISSUE 1887
58 DEVICE DISLOCATION 1885
59 DEVICE ISSUE 1883
60 INSOMNIA 1820
61 ABDOMINAL DISTENSION 1807
62 HYPOXIA 1802
63 MYALGIA 1766
64 CONSTIPATION 1765
65 SEASONAL ALLERGY 1761
66 FLUID OVERLOAD 1698
67 RIGHT VENTRICULAR FAILURE 1650
68 LOSS OF CONSCIOUSNESS 1639
69 DRUG INEFFECTIVE 1634
70 CARDIAC FAILURE 1614
71 ABDOMINAL PAIN 1610
72 DEHYDRATION 1592
73 DRUG INTOLERANCE 1561
74 DEVICE RELATED INFECTION 1559
75 INFUSION SITE INFECTION 1549
76 DYSPEPSIA 1500
77 ANAEMIA 1484
78 INFLUENZA 1472
79 INFUSION SITE HAEMORRHAGE 1441
80 CARDIAC FAILURE CONGESTIVE 1434
81 RESPIRATORY FAILURE 1434
82 URINARY TRACT INFECTION 1414
83 MUSCLE SPASMS 1412
84 COVID-19 1409
85 RASH 1409
86 ILLNESS 1404
87 PRURITUS 1403
88 SEPSIS 1323
89 MIGRAINE 1300
90 HOSPITALISATION 1293
91 ATRIAL FIBRILLATION 1264
92 SWELLING 1234
93 PULMONARY OEDEMA 1209
94 SINUSITIS 1207
95 RHINORRHOEA 1195
96 INFECTION 1194
97 GENERAL PHYSICAL HEALTH DETERIORATION 1183
98 INJECTION SITE PAIN 1162
99 HAEMOPTYSIS 1155
100 SOMNOLENCE 1151
101 GASTROINTESTINAL DISORDER 1141
102 INCORRECT DOSE ADMINISTERED 1109
103 DEVICE MALFUNCTION 1100
104 LUNG DISORDER 1082
105 ERYTHEMA 1079
106 CHILLS 1051
107 DEVICE LEAKAGE 1041
108 BRONCHITIS 1008
109 UNEVALUABLE EVENT 1004
110 OXYGEN CONSUMPTION INCREASED 994
111 DISEASE PROGRESSION 990
112 CARDIAC DISORDER 984
113 VASCULAR DEVICE INFECTION 979
114 GAIT DISTURBANCE 975
115 GASTROOESOPHAGEAL REFLUX DISEASE 968
116 GASTROINTESTINAL HAEMORRHAGE 967
117 TREMOR 967
118 TREATMENT NONCOMPLIANCE 964
119 JOINT SWELLING 955
120 INFUSION SITE DISCHARGE 938
121 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 912
122 HYPERTENSION 905
123 PERICARDIAL EFFUSION 884
124 HAEMOGLOBIN DECREASED 878
125 PLEURAL EFFUSION 869
126 ASCITES 862
127 RENAL FAILURE 852
128 THERAPY CESSATION 827
129 DRUG HYPERSENSITIVITY 822
130 HAEMORRHAGE 821
131 INJECTION SITE ERYTHEMA 816
132 DEVICE INFUSION ISSUE 815
133 PRESYNCOPE 812
134 DRY MOUTH 793
135 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 790
136 INFUSION SITE PRURITUS 772
137 CELLULITIS 770
138 HYPERVOLAEMIA 760
139 HYPERHIDROSIS 759
140 VISION BLURRED 750
141 RESPIRATORY TRACT CONGESTION 747
142 DYSPHONIA 744
143 BLOOD PRESSURE INCREASED 741
144 TACHYCARDIA 739
145 WHEEZING 722
146 DEVICE FAILURE 720
147 FLATULENCE 714
148 CONFUSIONAL STATE 708
149 ACUTE RESPIRATORY FAILURE 701
150 NECK PAIN 692
151 HYPOAESTHESIA 670
152 HYPERSENSITIVITY 666
153 INFUSION SITE INDURATION 662
154 CONTUSION 654
155 INFUSION SITE REACTION 652
156 PARAESTHESIA 651
157 DEVICE USE ERROR 650
158 UPPER RESPIRATORY TRACT INFECTION 634
159 BLOOD POTASSIUM DECREASED 633
160 DEVICE OCCLUSION 631
161 MEMORY IMPAIRMENT 631
162 DIZZINESS POSTURAL 630
163 DEPRESSION 616
164 FEELING HOT 605
165 RETCHING 605
166 CARDIAC ARREST 603
167 MUSCULAR WEAKNESS 599
168 INFUSION SITE WARMTH 597
169 INFUSION SITE IRRITATION 596
170 ACUTE KIDNEY INJURY 594
171 HOT FLUSH 594
172 THERAPY INTERRUPTED 588
173 LETHARGY 587
174 SINUS DISORDER 574
175 CATHETER SITE PAIN 564
176 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 561
177 INFLUENZA LIKE ILLNESS 559
178 THROMBOSIS 558
179 COMPLICATION ASSOCIATED WITH DEVICE 557
180 VISUAL IMPAIRMENT 556
181 CATHETER SITE ERYTHEMA 551
182 VIRAL INFECTION 544
183 PLATELET COUNT DECREASED 531
184 MYOCARDIAL INFARCTION 525
185 CEREBROVASCULAR ACCIDENT 522
186 RESPIRATION ABNORMAL 491
187 DEVICE BREAKAGE 484
188 INJECTION SITE DISCHARGE 484
189 RESPIRATORY DISTRESS 478
190 HEAD INJURY 476
191 PULMONARY ARTERIAL PRESSURE INCREASED 476
192 RENAL DISORDER 476
193 DEVICE MAINTENANCE ISSUE 472
194 PRODUCT DOSE OMISSION 471
195 HAEMATOCHEZIA 470
196 ARTHRITIS 469
197 HAEMOGLOBIN INCREASED 468
198 ADVERSE EVENT 458
199 THERAPY PARTIAL RESPONDER 455
200 INJECTION SITE HAEMORRHAGE 452
201 SCLERODERMA 452
202 STRESS 448
203 MUSCULOSKELETAL PAIN 447
204 SINUS CONGESTION 446
205 NERVOUSNESS 445
206 INTERSTITIAL LUNG DISEASE 440
207 CATHETER SITE HAEMORRHAGE 436
208 STAPHYLOCOCCAL INFECTION 434
209 OVERDOSE 433
210 DYSPNOEA AT REST 430
211 INJECTION SITE PRURITUS 427
212 URTICARIA 420
213 HEAD DISCOMFORT 419
214 THERAPY CHANGE 416
215 BALANCE DISORDER 413
216 LUNG TRANSPLANT 408
217 CLOSTRIDIUM DIFFICILE INFECTION 407
218 BLOOD PRESSURE ABNORMAL 405
219 HYPERSOMNIA 405
220 PULMONARY EMBOLISM 403
221 GASTROENTERITIS VIRAL 401
222 BONE PAIN 398
223 GOUT 398
224 SECRETION DISCHARGE 396
225 SWELLING FACE 393
226 SEIZURE 392
227 CATHETERISATION CARDIAC 391
228 PURULENT DISCHARGE 387
229 MOBILITY DECREASED 383
230 GASTRIC DISORDER 374
231 NEUROPATHY PERIPHERAL 363
232 LOCALISED INFECTION 361
233 BURNING SENSATION 359
234 HEART RATE IRREGULAR 356
235 HERPES ZOSTER 356
236 INFUSION SITE OEDEMA 356
237 DEVICE ALARM ISSUE 354
238 DYSGEUSIA 351
239 DEVICE POWER SOURCE ISSUE 350
240 HEART RATE DECREASED 349
241 ASTHMA 348
242 DECREASED ACTIVITY 348
243 INJECTION SITE INFECTION 347
244 RECTAL HAEMORRHAGE 342
245 HIP FRACTURE 341
246 ACCIDENTAL OVERDOSE 340
247 DYSPHAGIA 337
248 INFUSION SITE RASH 337
249 EXERCISE TOLERANCE DECREASED 336
250 SEPTIC SHOCK 335
251 ALOPECIA 334
252 CENTRAL VENOUS CATHETERISATION 334
253 LIVER DISORDER 334
254 HYPOACUSIS 331
255 SNEEZING 331
256 RASH PRURITIC 330
257 PULMONARY FIBROSIS 328
258 WEIGHT FLUCTUATION 326
259 CYANOSIS 324
260 RESPIRATORY TRACT INFECTION 323
261 INJECTION SITE SWELLING 321
262 LIMB DISCOMFORT 319
263 EAR INFECTION 318
264 INTENTIONAL DOSE OMISSION 317
265 PRODUCT ADMINISTRATION INTERRUPTED 317
266 SPUTUM DISCOLOURED 315
267 CATHETER SITE INFECTION 314
268 FEELING COLD 314
269 CATHETER SITE DISCHARGE 313
270 EXTRA DOSE ADMINISTERED 309
271 CATHETER SITE PRURITUS 304
272 INTENTIONAL PRODUCT USE ISSUE 303
273 RENAL IMPAIRMENT 303
274 BLOOD GLUCOSE INCREASED 302
275 INFUSION SITE DISCOLOURATION 301
276 LIMB INJURY 301
277 RESPIRATORY DISORDER 300
278 TRANSFUSION 300
279 INFUSION SITE DISCOMFORT 299
280 DEPRESSED MOOD 298
281 POLLAKIURIA 298
282 DRY SKIN 297
283 SYSTEMIC LUPUS ERYTHEMATOSUS 295
284 INTERNATIONAL NORMALISED RATIO INCREASED 292
285 ADVERSE DRUG REACTION 290
286 DEVICE DIFFICULT TO USE 289
287 FREQUENT BOWEL MOVEMENTS 289
288 BLOOD IRON DECREASED 287
289 DRUG TOLERANCE DECREASED 286
290 INFUSION SITE INFLAMMATION 285
291 MENTAL STATUS CHANGES 285
292 PRODUCT USE IN UNAPPROVED INDICATION 285
293 INFUSION SITE NODULE 284
294 SKIN IRRITATION 284
295 CATARACT 283
296 HYPOKALAEMIA 283
297 BACTERAEMIA 282
298 LOCALISED OEDEMA 282
299 SLEEP DISORDER 282
300 CHOKING SENSATION 280
301 THROMBOCYTOPENIA 280
302 DEVICE RELATED SEPSIS 279
303 DRY THROAT 279
304 DISCOMFORT 277
305 RALES 277
306 VERTIGO 275
307 HAEMATEMESIS 274
308 ARRHYTHMIA 273
309 INFUSION SITE EXTRAVASATION 273
310 DEVICE CONNECTION ISSUE 272
311 DEVICE PHYSICAL PROPERTY ISSUE 272
312 DEVICE USE ISSUE 272
313 INTERNAL HAEMORRHAGE 266
314 SKIN DISCOLOURATION 266
315 OROPHARYNGEAL DISCOMFORT 264
316 TINNITUS 260
317 EYE PAIN 258
318 DEVICE WIRELESS COMMUNICATION ISSUE 256
319 DRUG TITRATION ERROR 253
320 UNINTENTIONAL MEDICAL DEVICE REMOVAL 250
321 ATRIAL FLUTTER 249
322 NEURALGIA 249
323 BLOOD PRESSURE FLUCTUATION 246
324 FAECES DISCOLOURED 246
325 PALLOR 244
326 PNEUMOTHORAX 244
327 INFUSION SITE CELLULITIS 243
328 POST PROCEDURAL COMPLICATION 234
329 PANIC ATTACK 233
330 PRODUCT LEAKAGE 233
331 TASTE DISORDER 230
332 BLOOD PRESSURE SYSTOLIC DECREASED 229
333 ROAD TRAFFIC ACCIDENT 229
334 DIVERTICULITIS 228
335 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 228
336 BLOOD GLUCOSE DECREASED 227
337 MUSCULOSKELETAL CHEST PAIN 227
338 POOR QUALITY SLEEP 226
339 RESTLESS LEGS SYNDROME 225
340 BLISTER 224
341 UPPER-AIRWAY COUGH SYNDROME 224
342 OCULAR HYPERAEMIA 223
343 THROAT TIGHTNESS 223
344 BLOOD CREATININE INCREASED 222
345 GAIT INABILITY 222
346 FEELING JITTERY 220
347 EAR DISCOMFORT 219
348 THROMBOSIS IN DEVICE 219
349 DRUG INTERACTION 218
350 INTESTINAL OBSTRUCTION 218
351 CARDIOGENIC SHOCK 217
352 NEOPLASM MALIGNANT 215
353 FEEDING DISORDER 214
354 INJECTION SITE IRRITATION 214
355 NASAL DRYNESS 214
356 CARDIO-RESPIRATORY ARREST 212
357 INFUSION SITE BRUISING 212
358 MUSCULOSKELETAL STIFFNESS 211
359 OXYGEN SATURATION ABNORMAL 211
360 PULMONARY PAIN 210
361 ACCIDENTAL EXPOSURE TO PRODUCT 209
362 LABORATORY TEST ABNORMAL 208
363 BRAIN FOG 207
364 AMNESIA 205
365 EAR PAIN 205
366 EYE SWELLING 204
367 INFUSION SITE ABSCESS 202
368 CANDIDA INFECTION 201
369 INFUSION SITE VESICLES 200
370 NEPHROLITHIASIS 200
371 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 199
372 CATHETER SITE SWELLING 197
373 UNRESPONSIVE TO STIMULI 195
374 ORAL PAIN 194
375 RHINOVIRUS INFECTION 194
376 BACTERIAL INFECTION 193
377 IRRITABILITY 193
378 FAECES SOFT 192
379 HEPATIC CIRRHOSIS 192
380 BRONCHOSPASM 191
381 PRODUCT DOSE OMISSION IN ERROR 189
382 MATERNAL EXPOSURE DURING PREGNANCY 188
383 RESPIRATORY SYNCYTIAL VIRUS INFECTION 188
384 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 188
385 PRODUCT USE COMPLAINT 187
386 RIB FRACTURE 187
387 THERAPEUTIC RESPONSE DECREASED 186
388 BLOOD SODIUM DECREASED 185
389 MUSCULOSKELETAL DISCOMFORT 185
390 SLUGGISHNESS 185
391 CARDIAC FAILURE ACUTE 184
392 CATHETER MANAGEMENT 184
393 FUNGAL INFECTION 184
394 RASH ERYTHEMATOUS 184
395 CARDIOMEGALY 183
396 GENERALISED OEDEMA 183
397 INJECTION SITE RASH 182
398 TOOTHACHE 181
399 CATHETER PLACEMENT 180
400 HERNIA 180
401 CYSTITIS 179
402 ERUCTATION 179
403 GALLBLADDER DISORDER 179
404 BRAIN NATRIURETIC PEPTIDE INCREASED 178
405 RHEUMATOID ARTHRITIS 176
406 LOWER RESPIRATORY TRACT INFECTION 175
407 NIGHT SWEATS 174
408 SURGERY 174
409 LYMPHADENOPATHY 172
410 KIDNEY INFECTION 171
411 JOINT INJURY 169
412 LUNG NEOPLASM MALIGNANT 169
413 COVID-19 PNEUMONIA 168
414 COLD SWEAT 167
415 LACRIMATION INCREASED 167
416 STOMATITIS 167
417 PARANASAL SINUS HYPERSECRETION 166
418 DIALYSIS 165
419 INCORRECT DRUG ADMINISTRATION RATE 165
420 MULTIPLE ORGAN DYSFUNCTION SYNDROME 165
421 DEVICE INFORMATION OUTPUT ISSUE 164
422 WOUND 164
423 PATIENT DISSATISFACTION WITH TREATMENT 162
424 DIABETES MELLITUS 161
425 CHOKING 160
426 SUPRAVENTRICULAR TACHYCARDIA 160
427 CHOLELITHIASIS 159
428 AGEUSIA 158
429 SINUS HEADACHE 158
430 CEREBRAL HAEMORRHAGE 157
431 HYPONATRAEMIA 157
432 PULMONARY CONGESTION 157
433 SPEECH DISORDER 156
434 SLEEP APNOEA SYNDROME 154
435 APHONIA 153
436 BREATH SOUNDS ABNORMAL 153
437 PARANASAL SINUS DISCOMFORT 153
438 SICKLE CELL ANAEMIA WITH CRISIS 153
439 BENDOPNOEA 152
440 MEDICAL DEVICE COMPLICATION 152
441 PANCREATITIS 152
442 PULMONARY THROMBOSIS 151
443 BRADYCARDIA 150
444 LUNG INFECTION 150
445 INFUSION SITE MASS 149
446 SKIN INFECTION 149
447 DIZZINESS EXERTIONAL 148
448 HAEMATOMA 148
449 DEAFNESS 146
450 HAEMORRHOIDS 146
451 RASH MACULAR 146
452 SPINAL FRACTURE 146
453 HEPATIC FAILURE 145
454 LOWER LIMB FRACTURE 145
455 UPPER LIMB FRACTURE 145
456 MUSCLE TIGHTNESS 144
457 SKIN ULCER 144
458 WALKING DISTANCE TEST ABNORMAL 144
459 SENSITIVITY TO WEATHER CHANGE 142
460 INFLAMMATION 139
461 RESTLESSNESS 139
462 RIGHT VENTRICULAR DYSFUNCTION 139
463 DYSURIA 138
464 PULMONARY HAEMORRHAGE 137
465 WHITE BLOOD CELL COUNT INCREASED 137
466 SCIATICA 136
467 URINARY INCONTINENCE 136
468 DEVICE ADHESION ISSUE 135
469 DISORIENTATION 135
470 BLOOD POTASSIUM INCREASED 134
471 TERMINAL STATE 134
472 VAGINAL HAEMORRHAGE 134
473 ASPARTATE AMINOTRANSFERASE INCREASED 133
474 FLANK PAIN 133
475 BODY TEMPERATURE INCREASED 132
476 CATHETER SITE RASH 132
477 HEPATIC ENZYME INCREASED 131
478 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 131
479 INCORRECT DOSE ADMINISTERED BY DEVICE 131
480 WRONG DOSE 131
481 IRON DEFICIENCY ANAEMIA 129
482 GINGIVAL BLEEDING 128
483 INJECTION SITE REACTION 128
484 PRODUCT DISTRIBUTION ISSUE 128
485 AGITATION 127
486 BLOOD COUNT ABNORMAL 127
487 CARDIAC FLUTTER 127
488 HYPOPHAGIA 127
489 ILL-DEFINED DISORDER 127
490 ARTHROPATHY 126
491 MOOD ALTERED 126
492 EATING DISORDER 125
493 PRODUCT PHYSICAL ISSUE 124
494 SKIN DISORDER 124
495 DEVICE OPERATIONAL ISSUE 123
496 ORAL CANDIDIASIS 123
497 WHITE BLOOD CELL COUNT DECREASED 123
498 ABSCESS 122
499 IDIOPATHIC PULMONARY FIBROSIS 122
500 INJECTION SITE BRUISING 122
501 IRRITABLE BOWEL SYNDROME 122
502 SKIN LACERATION 122
503 TRANSIENT ISCHAEMIC ATTACK 122
504 DYSSTASIA 120
505 NASAL DISCOMFORT 120
506 MUSCLE STRAIN 119
507 PNEUMONITIS 119
508 SKIN EXFOLIATION 119
509 PERIPHERAL COLDNESS 118
510 PRODUCT ADMINISTRATION ERROR 118
511 SUBDURAL HAEMATOMA 118
512 TOOTH INFECTION 118
513 HALLUCINATION 117
514 PULMONARY VENO-OCCLUSIVE DISEASE 117
515 ANAL INCONTINENCE 116
516 HEART RATE ABNORMAL 116
517 ANKLE FRACTURE 115
518 LIVER FUNCTION TEST ABNORMAL 115
519 SARS-COV-2 TEST POSITIVE 115
520 DEEP VEIN THROMBOSIS 114
521 ELECTROLYTE IMBALANCE 114
522 GLOSSODYNIA 114
523 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 114
524 SHOCK 114
525 TRANSPLANT EVALUATION 114
526 COLITIS 113
527 FULL BLOOD COUNT DECREASED 113
528 RESPIRATORY TRACT IRRITATION 113
529 ALANINE AMINOTRANSFERASE INCREASED 112
530 PHOTOPHOBIA 112
531 CATHETER SITE IRRITATION 111
532 URINE OUTPUT DECREASED 111
533 INFUSION SITE PUSTULE 110
534 MENTAL DISORDER 110
535 ORAL DISCOMFORT 110
536 POST PROCEDURAL HAEMORRHAGE 110
537 PRODUCT QUALITY ISSUE 110
538 BEDRIDDEN 109
539 DEVICE ELECTRICAL FINDING 109
540 DISTURBANCE IN ATTENTION 109
541 ORTHOSTATIC HYPOTENSION 109
542 PAINFUL RESPIRATION 109
543 POLYURIA 109
544 GASTRITIS 108
545 IMPAIRED HEALING 108
546 PATIENT DISSATISFACTION WITH DEVICE 108
547 PHARYNGITIS STREPTOCOCCAL 108
548 RESPIRATORY ARREST 108
549 RESPIRATORY RATE INCREASED 108
550 BLOOD MAGNESIUM DECREASED 107
551 BACK DISORDER 106
552 EYE IRRITATION 106
553 EYE PRURITUS 106
554 HAEMODYNAMIC INSTABILITY 106
555 THIRST 106
556 DEVICE PLACEMENT ISSUE 104
557 EXPOSURE VIA SKIN CONTACT 104
558 EYE DISORDER 104
559 INJECTION SITE INDURATION 104
560 MELAENA 104
561 PROCEDURAL PAIN 104
562 CHRONIC KIDNEY DISEASE 103
563 FACE OEDEMA 103
564 HAEMATOCRIT DECREASED 103
565 PREMATURE BABY 103
566 TOOTH DISORDER 103
567 PULMONARY MASS 102
568 VASCULAR DEVICE OCCLUSION 102
569 DRY EYE 101
570 GASTRIC HAEMORRHAGE 101
571 BACK INJURY 100
572 LIP SWELLING 100
573 PNEUMONIA ASPIRATION 100
574 RED BLOOD CELL COUNT DECREASED 100
575 BLOOD PRESSURE SYSTOLIC INCREASED 98
576 DEVICE KINK 98
577 FACIAL PAIN 98
578 LIVER FUNCTION TEST INCREASED 98
579 VASODILATATION 98
580 BLOOD URINE PRESENT 97
581 FEMUR FRACTURE 97
582 FOOT FRACTURE 97
583 SKIN BURNING SENSATION 97
584 CRYING 96
585 ECHOCARDIOGRAM ABNORMAL 96
586 LIVER TRANSPLANT 96
587 LARYNGITIS 95
588 OCULAR DISCOMFORT 95
589 TRICUSPID VALVE INCOMPETENCE 95
590 CARBON DIOXIDE INCREASED 94
591 CHRONIC RESPIRATORY FAILURE 94
592 EXPOSURE DURING PREGNANCY 94
593 INFUSION SITE SCAR 94
594 BLOOD TEST ABNORMAL 93
595 GASTROENTERITIS 93
596 ORTHOPNOEA 93
597 UNDERDOSE 93
598 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 92
599 ANGINA PECTORIS 90
600 CARDIAC OPERATION 90
601 CHROMATURIA 90
602 FOOD POISONING 90
603 HAEMORRHOIDAL HAEMORRHAGE 90
604 PNEUMONIA BACTERIAL 90
605 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 90
606 TOXICITY TO VARIOUS AGENTS 90
607 AUTOIMMUNE DISORDER 89
608 COR PULMONALE 89
609 EAR CONGESTION 89
610 EMPHYSEMA 89
611 FRUSTRATION TOLERANCE DECREASED 89
612 MALNUTRITION 89
613 NEEDLE ISSUE 89
614 OSTEOMYELITIS 89
615 SCAR 89
616 STENT PLACEMENT 89
617 NOCTURNAL DYSPNOEA 88
618 OSTEOPOROSIS 88
619 TOOTH ABSCESS 87
620 GASTROINTESTINAL MOTILITY DISORDER 86
621 PRODUCT LABEL CONFUSION 86
622 PULMONARY ARTERIAL PRESSURE ABNORMAL 86
623 SENSITIVE SKIN 86
624 ABDOMINAL PAIN LOWER 85
625 ACUTE MYOCARDIAL INFARCTION 85
626 ENCEPHALOPATHY 85
627 HYPERKALAEMIA 85
628 HYPOGLYCAEMIA 85
629 RAYNAUD^S PHENOMENON 85
630 BLINDNESS 84
631 BREAST CANCER 84
632 INJURY 84
633 PULMONARY HYPERTENSIVE CRISIS 84
634 SARCOIDOSIS 84
635 THYROID DISORDER 84
636 WRIST FRACTURE 84
637 COLON CANCER 83
638 DIPLOPIA 83
639 HAEMATOLOGICAL INFECTION 83
640 INJECTION SITE WARMTH 83
641 JOINT STIFFNESS 83
642 MENTAL IMPAIRMENT 83
643 SMALL INTESTINAL OBSTRUCTION 83
644 ASPIRATION 82
645 EYE INFECTION 82
646 GASTROINTESTINAL PAIN 82
647 INSURANCE ISSUE 82
648 MIDDLE EAR EFFUSION 82
649 DISEASE COMPLICATION 81
650 DYSARTHRIA 81
651 ECZEMA 81
652 INFUSION SITE INJURY 81
653 ULCER 81
654 EYE HAEMORRHAGE 80
655 GASTROINTESTINAL INFECTION 80
656 VENTRICULAR TACHYCARDIA 80
657 APPLICATION SITE PRURITUS 78
658 BLOOD BILIRUBIN INCREASED 78
659 CATHETER SITE INFLAMMATION 78
660 CLOSTRIDIUM DIFFICILE COLITIS 78
661 RENAL FAILURE ACUTE 78
662 TOOTH EXTRACTION 78
663 UPPER GASTROINTESTINAL HAEMORRHAGE 78
664 BLOOD PRESSURE DIASTOLIC DECREASED 77
665 LOCAL SWELLING 77
666 NO ADVERSE EVENT 77
667 PNEUMONIA VIRAL 77
668 SKIN ABRASION 77
669 BLOOD ALKALINE PHOSPHATASE INCREASED 76
670 CATHETER SITE RELATED REACTION 76
671 DEMENTIA 76
672 ENDOCARDITIS 76
673 FEELING OF BODY TEMPERATURE CHANGE 76
674 HYPOAESTHESIA ORAL 76
675 LIGAMENT SPRAIN 76
676 ABNORMAL LOSS OF WEIGHT 75
677 HOSPICE CARE 75
678 MOUTH HAEMORRHAGE 75
679 NO THERAPEUTIC RESPONSE 75
680 CATHETERISATION CARDIAC ABNORMAL 74
681 PHARYNGEAL SWELLING 74
682 PROCEDURAL COMPLICATION 74
683 SCAB 74
684 SUDDEN DEATH 74
685 CATHETER SITE EXTRAVASATION 73
686 FOETAL EXPOSURE DURING PREGNANCY 73
687 PRODUCT RESIDUE PRESENT 73
688 STAPHYLOCOCCAL BACTERAEMIA 73
689 PRURITUS GENERALISED 72
690 SUTURE RELATED COMPLICATION 72
691 ADMINISTRATION SITE PAIN 71
692 CONCOMITANT DISEASE AGGRAVATED 71
693 LACERATION 71
694 PRODUCT PREPARATION ERROR 71
695 THROAT CLEARING 71
696 DEVICE DELIVERY SYSTEM ISSUE 70
697 IMPAIRED GASTRIC EMPTYING 70
698 MENORRHAGIA 70
699 THERAPEUTIC RESPONSE UNEXPECTED 70
700 AMMONIA INCREASED 69
701 ARTHROPOD BITE 69
702 BOWEL MOVEMENT IRREGULARITY 69
703 CARDIAC PACEMAKER INSERTION 69
704 CATHETER SITE VESICLES 69
705 COMA 69
706 HIATUS HERNIA 69
707 PELVIC FRACTURE 69
708 SUICIDAL IDEATION 69
709 TEMPERATURE INTOLERANCE 69
710 URINARY RETENTION 69
711 BLOOD CULTURE POSITIVE 68
712 CARDIAC DISCOMFORT 68
713 GASTRIC INFECTION 68
714 GASTRIC ULCER 68
715 LEFT VENTRICULAR FAILURE 68
716 PRODUCT COMMUNICATION ISSUE 68
717 RESPIRATORY TRACT INFECTION VIRAL 68
718 ACUTE RESPIRATORY DISTRESS SYNDROME 67
719 DIARRHOEA HAEMORRHAGIC 67
720 HEPATOMEGALY 67
721 HYPOVOLAEMIA 67
722 QUALITY OF LIFE DECREASED 67
723 APPLICATION SITE ERYTHEMA 66
724 ATELECTASIS 66
725 EMOTIONAL DISORDER 66
726 HYPOPNOEA 66
727 INFUSION SITE SCAB 66
728 MULTIPLE ALLERGIES 66
729 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 66
730 UNEVALUABLE DEVICE ISSUE 66
731 DRUG ADMINISTRATION ERROR 65
732 DYSKINESIA 65
733 FIBROMYALGIA 65
734 FOOD ALLERGY 65
735 INJECTION SITE VESICLES 64
736 PNEUMONIA INFLUENZAL 64
737 PRODUCT AFTER TASTE 64
738 PSEUDOMONAS INFECTION 64
739 BLOOD DISORDER 63
740 DECUBITUS ULCER 63
741 INCREASED APPETITE 63
742 MUSCLE TWITCHING 63
743 PULSELESS ELECTRICAL ACTIVITY 63
744 RASH GENERALISED 63
745 TACHYPNOEA 63
746 CIRCULATORY COLLAPSE 62
747 FINE MOTOR SKILL DYSFUNCTION 62
748 INTERVERTEBRAL DISC PROTRUSION 62
749 PANCYTOPENIA 62
750 PHYSICAL DECONDITIONING 62
751 PREMATURE DELIVERY 62
752 WOUND INFECTION 62
753 ACTIVITIES OF DAILY LIVING IMPAIRED 61
754 CARPAL TUNNEL SYNDROME 61
755 INJECTION SITE EXTRAVASATION 61
756 ULCER HAEMORRHAGE 61
757 EMOTIONAL DISTRESS 60
758 ENDOTRACHEAL INTUBATION 60
759 FAILURE TO THRIVE 60
760 GROIN PAIN 60
761 HAEMATURIA 60
762 HEAVY MENSTRUAL BLEEDING 60
763 HYPERTHYROIDISM 60
764 OSTEOARTHRITIS 60
765 PARAESTHESIA ORAL 60
766 ACNE 59
767 CARDIAC FAILURE CHRONIC 59
768 CHOLECYSTITIS 59
769 COMPRESSION FRACTURE 59
770 DEVICE RELATED THROMBOSIS 59
771 EXPIRED PRODUCT ADMINISTERED 59
772 INJECTION SITE DISCOLOURATION 59
773 INTERNATIONAL NORMALISED RATIO DECREASED 59
774 PHARYNGITIS 59
775 SKIN HAEMORRHAGE 59
776 CARDIAC ABLATION 58
777 DELIRIUM 58
778 DEVICE DEFECTIVE 58
779 FACE INJURY 58
780 GINGIVAL PAIN 58
781 INJECTION SITE DISCOMFORT 58
782 MEDICATION ERROR 58
783 NERVE COMPRESSION 58
784 OXYGEN THERAPY 58
785 TREATMENT FAILURE 58
786 TRISMUS 58
787 WEIGHT ABNORMAL 58
788 CORONAVIRUS INFECTION 57
789 HEPATIC FUNCTION ABNORMAL 57
790 HYPERVENTILATION 57
791 INFUSION SITE HAEMATOMA 57
792 PRODUCT ADHESION ISSUE 57
793 SCRATCH 57
794 VENTILATION PERFUSION MISMATCH 57
795 ATRIAL SEPTAL DEFECT 56
796 BLOOD GLUCOSE ABNORMAL 56
797 CORONARY ARTERY DISEASE 56
798 HAEMOGLOBIN ABNORMAL 56
799 IMPAIRED QUALITY OF LIFE 56
800 INJECTION SITE MASS 56
801 MITRAL VALVE INCOMPETENCE 56
802 PERICARDITIS 56
803 PHOTOSENSITIVITY REACTION 56
804 SICKLE CELL ANAEMIA 56
805 SPLENOMEGALY 56
806 BLOOD POTASSIUM ABNORMAL 55
807 COGNITIVE DISORDER 55
808 COLITIS ULCERATIVE 55
809 INCONTINENCE 55
810 INJECTION SITE CELLULITIS 55
811 INTESTINAL HAEMORRHAGE 55
812 SUTURE RUPTURE 55
813 THINKING ABNORMAL 55
814 BLOOD LOSS ANAEMIA 54
815 END STAGE RENAL DISEASE 54
816 FEAR 54
817 INTENTIONAL PRODUCT MISUSE 54
818 MECHANICAL VENTILATION 54
819 MULTI-ORGAN FAILURE 54
820 PREGNANCY 54
821 SALIVARY HYPERSECRETION 54
822 VIRAL UPPER RESPIRATORY TRACT INFECTION 54
823 BLADDER DISORDER 53
824 CORONARY ARTERY OCCLUSION 53
825 DEAFNESS UNILATERAL 53
826 DEVICE PROGRAMMING ERROR 53
827 DRUG ABUSE 53
828 DRUG DOSE TITRATION NOT PERFORMED 53
829 HEPATIC ENCEPHALOPATHY 53
830 INTERNATIONAL NORMALISED RATIO ABNORMAL 53
831 JAW DISORDER 53
832 LOWER RESPIRATORY TRACT CONGESTION 53
833 OESOPHAGEAL DISORDER 53
834 TENDERNESS 53
835 ABASIA 52
836 APPENDICITIS 52
837 BLOOD UREA INCREASED 52
838 CARDIAC VALVE DISEASE 52
839 COAGULOPATHY 52
840 HIP ARTHROPLASTY 52
841 INTRA-ABDOMINAL FLUID COLLECTION 52
842 RIGHT VENTRICULAR DILATATION 52
843 SKIN REACTION 52
844 SPINAL COMPRESSION FRACTURE 52
845 STAPHYLOCOCCAL SEPSIS 52
846 SWOLLEN TONGUE 52
847 ACCIDENT 51
848 CARDIAC TAMPONADE 51
849 CONCUSSION 51
850 HAEMORRHAGE INTRACRANIAL 51
851 HYPERCAPNIA 51
852 POST-TUSSIVE VOMITING 51
853 PRODUCT AVAILABILITY ISSUE 51
854 UROSEPSIS 51
855 APHASIA 50
856 APPLICATION SITE PAIN 50
857 CARDIOPULMONARY FAILURE 50
858 CONVULSION 50
859 DEPENDENCE ON OXYGEN THERAPY 50
860 INFUSION SITE URTICARIA 50
861 MASS 50
862 MICTURITION URGENCY 50
863 MUSCLE ATROPHY 50
864 POOR PERIPHERAL CIRCULATION 50
865 SENSATION OF FOREIGN BODY 50
866 SINUS PAIN 50
867 ACUTE RIGHT VENTRICULAR FAILURE 49
868 CARDIAC DYSFUNCTION 49
869 CATHETER SITE WARMTH 49
870 DEVICE DAMAGE 49
871 EYE CONTUSION 49
872 ORAL HERPES 49
873 PARACENTESIS 49
874 POST PROCEDURAL INFECTION 49
875 TOOTH FRACTURE 49
876 TROPONIN INCREASED 49
877 ABNORMAL DREAMS 48
878 APPETITE DISORDER 48
879 CARDIAC MURMUR 48
880 DERMATITIS ALLERGIC 48
881 GLAUCOMA 48
882 HEPATIC CANCER 48
883 HYSTERECTOMY 48
884 INCREASED UPPER AIRWAY SECRETION 48
885 INJECTION SITE OEDEMA 48
886 NIGHTMARE 48
887 PAIN OF SKIN 48
888 RENAL PAIN 48
889 VITREOUS FLOATERS 48
890 CARDIAC FAILURE HIGH OUTPUT 47
891 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47
892 INJECTION SITE SCAB 47
893 IRON DEFICIENCY 47
894 PORTAL HYPERTENSION 47
895 RASH PAPULAR 47
896 TENSION HEADACHE 47
897 BRONCHIECTASIS 46
898 EMERGENCY CARE 46
899 HAEMATOCRIT INCREASED 46
900 LARGE INTESTINE POLYP 46
901 MACULAR DEGENERATION 46
902 MIDDLE INSOMNIA 46
903 MUCOUS STOOLS 46
904 PERIORBITAL SWELLING 46
905 PRODUCT STORAGE ERROR 46
906 SINUS TACHYCARDIA 46
907 SKIN LESION 46
908 SYRINGE ISSUE 46
909 ANOSMIA 45
910 CHOLECYSTECTOMY 45
911 FRACTURE 45
912 HYPERGLYCAEMIA 45
913 INJECTION SITE INFLAMMATION 45
914 MOVEMENT DISORDER 45
915 ADMINISTRATION SITE ODOUR 44
916 BREAST PAIN 44
917 CHOLECYSTITIS INFECTIVE 44
918 HYPOTHYROIDISM 44
919 PANIC REACTION 44
920 PSORIASIS 44
921 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 44
922 SUFFOCATION FEELING 44
923 ABNORMAL FAECES 43
924 INABILITY TO AFFORD MEDICATION 43
925 PHARYNGEAL OEDEMA 43
926 PRODUCT PREPARATION ISSUE 43
927 TONGUE DISCOMFORT 43
928 TRANSPLANT 43
929 ASTHENOPIA 42
930 INCREASED TENDENCY TO BRUISE 42
931 PRODUCT CONTAINER ISSUE 42
932 PULMONARY ALVEOLAR HAEMORRHAGE 42
933 PULMONARY FUNCTION TEST DECREASED 42
934 ROTATOR CUFF SYNDROME 42
935 SKIN CANCER 42
936 SKIN TIGHTNESS 42
937 UPPER RESPIRATORY TRACT CONGESTION 42
938 ABNORMAL BEHAVIOUR 41
939 BRAIN INJURY 41
940 COLONOSCOPY 41
941 CONJUNCTIVITIS 41
942 COR PULMONALE CHRONIC 41
943 DEFAECATION URGENCY 41
944 DENTAL CARIES 41
945 DEPRESSED LEVEL OF CONSCIOUSNESS 41
946 ESCHERICHIA INFECTION 41
947 HUNGER 41
948 INFUSION SITE HYPERSENSITIVITY 41
949 LOWER GASTROINTESTINAL HAEMORRHAGE 41
950 LYMPHOEDEMA 41
951 PRODUCT SUBSTITUTION ISSUE 41
952 CATHETER REMOVAL 40
953 CREPITATIONS 40
954 DERMATITIS 40
955 DEVICE LOOSENING 40
956 ELECTROCARDIOGRAM ABNORMAL 40
957 INJECTION SITE PUSTULE 40
958 INTRACARDIAC PRESSURE INCREASED 40
959 NODULE 40
960 THERAPEUTIC PRODUCT EFFECT VARIABLE 40
961 AORTIC STENOSIS 39
962 CARDIAC OUTPUT DECREASED 39
963 DRUG DELIVERY SYSTEM MALFUNCTION 39
964 DRUG WITHDRAWAL SYNDROME 39
965 LUNG INFILTRATION 39
966 POLYP 39
967 SKIN WARM 39
968 ANAPHYLACTIC REACTION 38
969 APATHY 38
970 CATHETER SITE SCAB 38
971 DYSENTERY 38
972 EXTRASYSTOLES 38
973 GASTROINTESTINAL SOUNDS ABNORMAL 38
974 GLOSSITIS 38
975 HYPOTONIA 38
976 IMMUNE SYSTEM DISORDER 38
977 INJECTION SITE ABSCESS 38
978 MOOD SWINGS 38
979 OESOPHAGITIS 38
980 OXYGEN SUPPLEMENTATION 38
981 PAROSMIA 38
982 ANEURYSM 37
983 ANGIOEDEMA 37
984 BLADDER CANCER 37
985 BLOOD ELECTROLYTES DECREASED 37
986 CAESAREAN SECTION 37
987 CYST 37
988 INCOHERENT 37
989 INITIAL INSOMNIA 37
990 JUGULAR VEIN DISTENSION 37
991 LYMPHOMA 37
992 MYOCARDIAL NECROSIS MARKER INCREASED 37
993 NERVOUS SYSTEM DISORDER 37
994 PRODUCT DEPOSIT 37
995 RED BLOOD CELL COUNT INCREASED 37
996 RHINITIS 37
997 THERAPEUTIC RESPONSE SHORTENED 37
998 APPLICATION SITE IRRITATION 36
999 CLAVICLE FRACTURE 36